WednesdayApr 03, 2024 2:44 pm

QualityStocksNewsBreaks – U-BX Technology (NASDAQ: UBXG) Closes on $10M Public Offering

U-BX Technology (NASDAQ: UBXG), an artificial intelligence-driven, value-added services and products provider to insurance carriers, has closed on its initial public offering. The offering, which closed on April 1, 2024, comprised 2 million ordinary shares at an initial public offering price of $5 per share, resulting in gross proceeds of $10 million before standard deductions and offering expenses. In addition, the company granted the underwriter an option to purchase up to an additional 300,000 shares at the public offering price to cover any overallotments. U-BX Technology anticipates using the funds from the offering for research and development, advertising and marketing,…

Continue Reading

TuesdayApr 02, 2024 3:45 pm

QualityStocksNewsBreaks – Bravo Multinational Inc. (BRVO) Solidifies Entry into Video Streaming Industry

Bravo (OTC: BRVO), a company actively exploring opportunities in the entertainment, hospitality and technology sectors, is looking at streaming to generate long-term value for its shareholders through high-growth business ventures. “Bravo recently announced entering into a purchase agreement to acquire the assets of Streaming TVEE Inc., solidifying its entry into the video streaming industry. The company’s strategic move establishes the business foundation for the previously announced flagship offering, TVee NOW(TM), which is expected to launch a Beta version during Q1 2024. The streaming service will be available for download in the Roku Channel Store, Apple Store and Google Play Store……

Continue Reading

TuesdayApr 02, 2024 3:22 pm

QualityStocksNewsBreaks – AppTech Payments Corp. (NASDAQ: APCX) Closes on $2M Common Stock Public Offering

AppTech Payments (NASDAQ: APCX), a pioneering fintech company powering frictionless commerce, has closed on a previously announced underwritten public offering. The offering was comprised of 2,000,000 shares of common stock at $1 per share. The offering is valued at an estimated $2 million in gross proceeds, before deducting underwriting discounts and other offering expenses. The announcement noted that APCX also granted the underwriters a 45-day option to purchase up to an additional 300,000 shares of common stock to cover any overallotments. EF Hutton LLC acted as sole bookrunner for the offering. To view the full press release, visit https://ibn.fm/tvoYx About…

Continue Reading

TuesdayApr 02, 2024 3:09 pm

QualityStocksNewsBreaks – Astrotech Corp. (NASDAQ: ASTC), Subsidiary Set to Spotlight Tracer 1000 Trace Detector at Leading Security Trade Event

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its wholly owned subsidiary, 1st Detect Corporation, will be showcasing the TRACER 1000 Narcotics Trace Detector (“NTD”) and Explosives Trace Detector (“ETD”) at the International Security Conference and Exposition. Known as ISC West, the conference and expo is slated to run April 9–12, 2024, in Las Vegas; the event is the one of the leading comprehensive security trade events in the nation and will be attended by key security and public-safety professionals. A high-performance laboratory instrument powered by Astrotech Mass Spectrometer Technology(TM), the TRACER 1000 can detect trace levels of narcotics…

Continue Reading

TuesdayApr 02, 2024 3:01 pm

QualityStocksNewsBreaks – Danimer Scientific Inc. (NYSE: DNMR) Secures ~$15M in Registered Direct

Danimer Scientific (NYSE: DNMR) is a leading next- generation bioplastics company focused on the development and production of biodegradable materials. The company recently announced the closing of its registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accompanying warrants to purchase up to an aggregate of 15,000,000 shares of common stock. Danimer secured approximately $15 million in gross proceeds, of which it intends to use the net for working capital and…

Continue Reading

TuesdayApr 02, 2024 2:49 pm

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Releases Q4, FY 2023 Financial Report Reflect Focus on Core Healthcare Network

HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, is reporting financial results for Q4 and full year ended Dec. 31, 2023. A highlight of the report includes that, based on “strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.” The report noted that the company’s strategic focus and technological innovations are paving the way for an optimistic outlook with optimization of operational expenses leading to a 52% cut in operational losses. In…

Continue Reading

TuesdayApr 02, 2024 1:35 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing Genprex’s non-viral Oncoprex(R) Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer (“NSCLC”) in a humanized mouse model. “These positive preclinical data are very encouraging and support NPRL2 gene therapy as a potential treatment for a sub-group of NSCLC in which patients traditionally are resistant to existing therapies,” said Rodney Varner, president, chairman and CEO at Genprex. “We…

Continue Reading

TuesdayApr 02, 2024 1:09 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released financial results for the full year ending Dec. 31, 2023; the company also reported on corporate and clinical development achievement for the year. Highlights of the report included that Berubicin, the company’s lead program, has passed preplanned interim futility analysis milestones with a recommendation to proceed without modification into a potentially pivotal glioblastoma multiforme (“GBM”) study, and enrollment for the Berubicin study has been completed with topline data expected in first half…

Continue Reading

TuesdayApr 02, 2024 12:21 pm

QualityStocksNewsBreaks – Zoned Properties Inc. (ZDPY) Refocusing Investment Portfolio to Potentially Unlock Equity

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is seeking to capitalize on the U.S. cannabis industry’s burgeoning future by targeting commercial properties with the potential to be acquired and rezoned or permitted for specific purposes. “Zoned Properties maintains a portfolio of six investment properties located across Arizona, Michigan and Illinois, with each of its leased properties occupied by commercial cannabis-linked businesses. The company currently enjoys a 100% occupancy rate with a weighted average lease term of over 10 years. In addition to maintaining four properties leased and repurposed as regulated cannabis retail…

Continue Reading

TuesdayApr 02, 2024 11:40 am

QualityStocksNewsBreaks – Astiva Health Setting New Standard for Patient-Centric Care

Astiva Health, a leading provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, is championing a model of care that emphasizes proactive health management and a healthy lifestyle over traditional reactive methods. “At the core of Astiva Health’s innovative approach is the principle of patient-centric care. This method prioritizes the active involvement of patients in their healthcare decisions, ensuring their preferences, needs and values guide their care plans… A critical element in Astiva Health’s strategy is the development of a supportive health community. This community – encompassing healthcare professionals, family, caregivers, and peer groups – provides…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered